Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Döntéstámogatás a beültethető kardioverter-defibrillátor impulzusgenerátor cseréjével szembesülő felnőtteknél

2026. augusztus 14. frissítette: Ottawa Heart Institute Research Corporation

A beültethető kardioverter-defibrillátor impulzusgenerátor cseréje előtt álló felnőttek döntéstámogatásának értékelése: Megvalósíthatósági tanulmány

The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, the investigators developed PDA for ICD replacement. The purpose of this feasibility trial is to collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Eligible and consented participants facing ICD replacement will be randomized to receive the decision aid or to usual care. The investigators will assess if this decision aid can improve participants' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.

A tanulmány áttekintése

Részletes leírás

Sudden cardiac death (SCD) due to a ventricular arrhythmia is a serious cause of cardiovascular death in Canada. The implantable cardioverter defibrillator (ICD) can reduce the incidence of SCD in high-risk patients by delivering an internal shock to restore a normal rhythm. The life expectancy of an ICD generator is estimated between four and seven years, and must be surgically replaced to ensure ongoing function. Implantable cardioverter-defibrillator (ICD) replacement is becoming increasingly common constituting nearly 40% of all ICD procedures. For the most part, ICDs are automatically replaced. With every ICD replacement, the net benefit of continued ICD therapy should be assessed individually in view of the procedural risks, inappropriate shocks, psychological risks, changes in health status, and the potential for harm and suffering at end-of-life. Some studies have shown that the mortality benefit of an ICD attenuates with advancing age and comorbidities.

There are many legitimate reasons for declining ICD generator replacement. The chronic nature of a cardiac condition and/or the diagnosis of a life-limiting disease since initial implantation may compel a patient to reconsider their health care goals from supporting quantity of life, to prioritizing one of quality. This is an important distinction as the ICD can prolong the dying process by delivering shock(s) which can result in pain and discomfort for the patient, and helplessness for witnesses. Other patients have reported psychological distress, while others report only truly understanding the effects of living with an ICD after receiving one, possibly leading to changes in treatment preference when they are faced with the decision to replace. Also, the replacement procedure includes a substantially greater risk for infection and reoperation as compared to the initial implantation.

These complexities warrant decision support to prepare patients to make decisions. Yet, no means exists to support patients' decision-making in the context of ICD replacement. A decision support intervention (including a patient decision aid with decision coaching) was developed using a user-centered design with various stakeholders and potential end-users, which could moderate treatment related uncertainty and prepare patients to make high quality decisions that are informed and based on their personal preferences and values.

Objectives:

  1. Conduct a pilot randomized controlled trial (RCT) to determine the feasibility of conducting a larger trial.
  2. To determine the effect of the decision support intervention for adults faced with ICD replacement on attributes of decision quality and decision-making processes

Tanulmány típusa

Beavatkozó

Beiratkozás (Tényleges)

30

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi helyek

    • Ontario
      • Ottawa, Ontario, Kanada, K1Y 4W7
        • University of Ottawa Heart Institute

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

18 év és régebbi (Felnőtt, Idősebb felnőtt)

Egészséges önkénteseket fogad

Nem

Tanulmányozható nemek

Összes

Leírás

Inclusion Criteria:

  • ICD battery nearing depletion or at elective replacement indicator
  • Able to speak and read in English
  • Able to provide informed consent; or if incapable of providing informed consent, can be obtained by the patient's appointed substitute decision-maker or power of attorney for personal care.

Exclusion Criteria:

  • Participants and/or substitute decision maker unable to understand the patient decision aid or decision coaching session due to language barrier or visual impairment
  • Participants with cardiac resynchronization therapy (CRT) or participants eligible for an upgrade to CRT.
  • Participants with conduction system disease who are pacemaker dependent

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Egészségügyi szolgáltatások kutatása
  • Kiosztás: Véletlenszerűsített
  • Beavatkozó modell: Párhuzamos hozzárendelés
  • Maszkolás: Egyetlen

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Kísérleti: Decision support

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

Nincs beavatkozás: Usual care

The control group will not receive the decision support intervention prior to consultation with the physician.

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Pilot RCT (Feasibility Measure): Participant Referral/Recruitment Rate.
Időkeret: Baseline to 12 months
Baseline to 12 months
Pilot RCT (Feasibility Measure): Completion of Decision Support Intervention
Időkeret: Baseline to 6 months

In this feasibility RCT, the feasibility regarding key processes to the success of a larger trial will be assessed. The investigators will descriptively collect the rate of participants who complete the decision support intervention.

Baseline to 6 months
Percentage of Participants With Missing Questionnaires
Időkeret: Baseline to 6 months

The percentage of participants with missing questionnaire data is reported.

Baseline to 6 months

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Knowledge
Időkeret: Measured at 2-4 week Follow Up

The investigators developed a knowledge test based on the content of the patient decision aid. It was endorsed for validity by the Patient Decision Aid (PtDA) development team using a standardized template in the form of true or false questions. There are six questions meant to assess a patient's understanding of their heart condition, treatment options, and risks and benefits of each option. Reported scores are the mean percentage of correctly answered questions from the knowledge based test.

Measured at 2-4 week Follow Up
Decisional Conflict
Időkeret: 1 month, 6 months, 12 months follow-up

The Decisional Conflict Scale measures a person's perception of the difficulty in making a decision, the extent to which they feel uncertain about treatment options, are knowledgeable about the risks and benefits of options, clear about personal values, and supported in decision making. The scale has good test-retest reliability (Cronbach's alpha coefficients > 0.78) and predictive validity.

The scores for each item range from 0-4. The scores for all items are summed, then divided by 16 and multiplied by 25. Total scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

Scores lower than 25 are associated with decision implementation and scores higher than 37.5 are associated with delayed decisions.

1 month, 6 months, 12 months follow-up
Preferred Option
Időkeret: Assessed at 2-4 weeks

Preferred option will be measured by asking patients whether they prefer to have their ICD's pulse generator replaced, not replaced, or whether they are unsure using the 15-point Choice Predisposition Scale that demonstrates a patient's inclination toward a given option. This scale has a test-retest coefficient >0.90.

Score scale 1-15 with lower scores indicating a preference to not replacing the ICD, and high scores toward replacing.

Assessed at 2-4 weeks
Perceptions of Involvement in Decision-making at 6Months
Időkeret: at 6 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 6 month follow up
Perceptions of Involvement in Decision-making at 12Months
Időkeret: at 12 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 12 month follow up
The Medical Outcomes Trust Short Form (SF-36v2)
Időkeret: Baseline visit intervention and usual care groups

The SF-36 is a reliable and valid generic health related quality of life scale (HRQL) comprised of 36 items. Associations between HRQL and decision choice will be made.

Score ranges from 0 to 100. Higher scores indicate better perception of health.

Baseline visit intervention and usual care groups
Acceptability and Usability of Patient Decision Aid
Időkeret: 1 month; intervention group only

Intervention group participants will be asked common acceptability and usability questions extensively used for evaluating PtDAs during development (Barry, Cherkin, Chang, Fowler, & Skates, 1997; Kushniruk & Patel, 2004; O'Connor & Cranney, 2002).

Results are reported as the number of participants selecting the highest acceptability for each category with the most positive answer in parenthesis in the row title.

1 month; intervention group only
Participant Satisfaction With Decision Coaching
Időkeret: 1 month; intervention group only

Patients' satisfaction with decision coaching will be measured using the Genetic Counseling Satisfaction Scale and perceptions of decision coach neutrality (Schwalm, Stacey, Pericak, & Natarajan, 2012; Tercyak, Johnson, Roberts, & Cruz, 2001). This scale has face validity and a reliability coefficient of alpha 0.80 to 0.90 in genetic counselling contexts with adults.

Results are reported as number of participants that rated the highest satisfaction for each question, with the most positive response in parentheses in the row name.

1 month; intervention group only

Egyéb eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Actual Choice at 6months
Időkeret: 6 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement, or decline ICD replacement. Only participants that were required to make a final decision and procedure dates occurred at the 6 month timeline.

6 month followup; intervention and usual care groups
Actual Choice at 12months
Időkeret: 12 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement or decline ICD replacement. Results include only those participants required to make a final decision, with procedure dates up to the 12month follow-up. Note that the results at 12months include those at 6months as cumulative data.

12 month followup; intervention and usual care groups
Survival
Időkeret: 6 months, 12 months; intervention and usual care groups14

The number of participants who are alive or dead at 6 months and 12months.

6 months, 12 months; intervention and usual care groups14

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Nyomozók

  • Tanulmányi igazgató: Dawn Stacey, RN, PhD, University of Ottawa; Ottawa Hospital Research Institute

Publikációk és hasznos linkek

A vizsgálattal kapcsolatos információk beviteléért felelős személy önkéntesen bocsátja rendelkezésre ezeket a kiadványokat. Ezek bármiről szólhatnak, ami a tanulmányhoz kapcsolódik.

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete

2016. április 1.

Elsődleges befejezés (Tényleges)

2018. április 1.

A tanulmány befejezése (Tényleges)

2018. október 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2016. január 15.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2016. január 26.

Első közzététel (Becsült)

2016. január 29.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. november 9.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. augusztus 14.

Utolsó ellenőrzés

2022. április 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

NEM

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel